| Sarah Bergstrand, LPN | |
|
2518 1st Ave S, Minneapolis, MN 55404-4317 | |
| (615) 872-0495 | |
| Not Available |
| Full Name | Sarah Bergstrand |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2518 1st Ave S, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447866975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 820854 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Bergstrand, LPN 2518 1st Ave S, Minneapolis, MN 55404-4317 Ph: (615) 872-0495 | Sarah Bergstrand, LPN 2518 1st Ave S, Minneapolis, MN 55404-4317 Ph: (615) 872-0495 |
News Archive
Advanced Cell Technology, Inc. or "ACT" reported that a range of therapeutic cell types obtained from induced pluripotent stem (iPS) cells exhibit abnormal expansion and early cellular aging. The research, which appears online (published-ahead-of- print) in the journal STEM CELLS by ACT and its collaborators at Stem International (SCRMI), Harvard Medical School, and the University of Illinois, compares a variety of replacement cell types derived from human iPS cells with their embryonic stem (ES) cell counterparts. The findings support the use of ACT's single blastomere-derived human embryonic stem cell lines which do not display early aging.
Digestive Care, Inc. (DCI) announced today that the company has received a complete response letter from the U.S. Food and Drug Administration (FDA) and has moved closer to obtaining approval of its New Drug Application (NDA) for PANCRECARB((R) )(pancrelipase) used for the treatment of Exocrine Pancreatic Insufficiency.
BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase in development for the treatment of Pompe disease.
The Food and Drug Administration (FDA) is reportedly about to issue "blackbox" warnings for drugs used to enhance the images of ultrasound machines in the diagnosing of heart problems.
Today GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing Data Analysis Suite.
› Verified 3 days ago
Cynthia Haima, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 245 Clifton Ave, Minneapolis, MN 55403 Phone: 612-870-3787 | |
Brian Moen, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 433 S 7th St Apt 1923, Minneapolis, MN 55415 Phone: 612-305-0972 | |
Gail Elizabeth Rousseau, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1300 Godward St Ne, Minneapolis, MN 55413 Phone: 612-353-4669 Fax: 612-354-2403 | |
Sydne Adams, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2200 1st Ave S, Minneapolis, MN 55404 Phone: 612-871-7567 Fax: 612-767-8749 | |
Jolyn Means, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-725-2000 | |
Yasmin Farah, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 951 Lowry Ave Ne Apt 304, Minneapolis, MN 55418 Phone: 612-229-3455 | |
Charlie Dillon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 245 Clifton Ave, Minneapolis, MN 55403 Phone: 612-870-3787 |